Related references
Note: Only part of the references are listed.Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis
Bruce A. Corliss et al.
MICROCIRCULATION (2016)
Monocyte-endothelial cell interactions in the regulation of vascular sprouting and liver regeneration in mouse
Pedro Melgar-Lesmes et al.
JOURNAL OF HEPATOLOGY (2015)
Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9
Umeharu Ohto et al.
NATURE (2015)
Development and functions of the choroid plexus-cerebrospinal fluid system
Melody P. Lun et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Development of the choroid plexus and blood-CSF barrier
Shane A. Liddelow
FRONTIERS IN NEUROSCIENCE (2015)
TLR9 and TLR7/8 activation induces formation of keratic precipitates and giant macrophages in the mouse cornea
Holly R. Chinnery et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
TLR9 Agonist Regulates Angiogenesis and Inhibits Corneal Neovascularization
Jiahui Wu et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
The role of macrophage phenotype in vascularization of tissue engineering scaffolds
Kara L. Spiller et al.
BIOMATERIALS (2014)
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Theerawut Chanmee et al.
CANCERS (2014)
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis
V. Damiano et al.
BRITISH JOURNAL OF CANCER (2013)
The radiosensitizing effect of CpG ODN107 on human glioma cells is tightly related to its antiangiogenic activity via suppression of HIF-1α/VEGF pathway
Dan Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Hydrazinocurcumin Encapsuled Nanoparticles Re-Educate Tumor-Associated Macrophages and Exhibit Anti-Tumor Effects on Breast Cancer Following STAT3 Suppression (Publication with Expression of Concern. See vol. 14, 2019)
Xiwen Zhang et al.
PLOS ONE (2013)
Choroid Sprouting Assay: An Ex Vivo Model of Microvascular Angiogenesis
Zhuo Shao et al.
PLOS ONE (2013)
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway
Claudia Volpi et al.
NATURE COMMUNICATIONS (2013)
Oligonucleotide conjugates for therapeutic applications
Johannes Winkler
THERAPEUTIC DELIVERY (2013)
TLR9 Ligand CpG-ODN Applied to the Injured Mouse Cornea Elicits Retinal Inflammation
Holly R. Chinnery et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
An essential role for Rax in retina and neuroendocrine system development
Yuki Muranishi et al.
DEVELOPMENT GROWTH & DIFFERENTIATION (2012)
Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system
Nobutaka Hanagata
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Use of the mouse aortic ring assay to study angiogenesis
Marianne Baker et al.
NATURE PROTOCOLS (2012)
Environmental conditioning in the control of macrophage thrombospondin-1 production
Jezrom B. Fordham et al.
SCIENTIFIC REPORTS (2012)
Basic and Therapeutic Aspects of Angiogenesis
Michael Potente et al.
CELL (2011)
Transplantation of Human Pericyte Progenitor Cells Improves the Repair of Infarcted Heart Through Activation of an Angiogenic Program Involving Micro-RNA-132
Rajesh Katare et al.
CIRCULATION RESEARCH (2011)
TLR-signaling Networks: An Integration of Adaptor Molecules, Kinases, and Cross-talk
J. Brown et al.
JOURNAL OF DENTAL RESEARCH (2011)
Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
Alenka Kuznik et al.
JOURNAL OF IMMUNOLOGY (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Toll-Like Receptors in Angiogenesis
Karsten Grote et al.
THESCIENTIFICWORLDJOURNAL (2011)
Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation
Ine M. J. Wolfs et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Protective and pathogenic functions of macrophage subsets
Peter J. Murray et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Human Adult Vena Saphena Contains Perivascular Progenitor Cells Endowed With Clonogenic and Proangiogenic Potential
Paola Campagnolo et al.
CIRCULATION (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Animal models of choroidal and retinal neovascularization
Hans E. Grossniklaus et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodeling
Andrew N. Makanya et al.
ANGIOGENESIS (2009)
TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA
Annapoorani Chockalingam et al.
IMMUNOLOGY AND CELL BIOLOGY (2009)
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
Marcin Kortylewski et al.
NATURE BIOTECHNOLOGY (2009)
The DNA sugar backbone 2′ deoxyribose determines toll-like receptor 9 activation
Tobias Haas et al.
IMMUNITY (2008)
Regulation of multiple angiogenic pathways by D114 and Notch in human umbilical vein endothelial cells
Laura S. Harrington et al.
MICROVASCULAR RESEARCH (2008)
Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
A. M. Krieg
ONCOGENE (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells
Ikuo Yana et al.
JOURNAL OF CELL SCIENCE (2007)
Development of TLR9 agonists for cancer therapy
Arthur M. Krieg
JOURNAL OF CLINICAL INVESTIGATION (2007)
Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Mats Hellstroem et al.
NATURE (2007)
Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function
CK Williams et al.
BLOOD (2006)
Novel Toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors
V Damiano et al.
CLINICAL CANCER RESEARCH (2006)
M phi 1 and M phi 2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals
Alexei Gratchev et al.
IMMUNOBIOLOGY (2006)
Therapeutic potential of Toll-like receptor 9 activation
Arthur M. Krieg
NATURE REVIEWS DRUG DISCOVERY (2006)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis
U Ozerdem et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
In vivo angiogenic phenotype of endothelial cells and pericytes induced by vascular endothelial growth factor-A
AN Witmer et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
Intussusceptive angiogenesis: Its emergence, its characteristics, and its significance
PH Burri et al.
DEVELOPMENTAL DYNAMICS (2004)
Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation
J Vollmer et al.
IMMUNOLOGY (2004)
Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits
HD Danenberg et al.
CIRCULATION (2002)
Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes
J Vollmer et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity
E Davila et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
